Clinical and demographic characteristics | Discharged alive | Death in the ICU | Crude RR (95%CI) | Adjusted OR (95%CI) | Adjusted p value |
---|---|---|---|---|---|
Female | 69.4 (84/121) | 30.6 (37/121) | – | – | – |
Male | 69.9 (93/133) | 30.1 (40/133) | 0.98 (0.68–1.43) | 0.83 (0.45–1.52) | 0.553 |
Age in years | 57 (41–71) | 62 (52–71) | 1.02 (1.00–1.03) | 1.00 (0.98–1.02) | 0.781 |
APACHE II score | 20 (16–26) | 27 (21–31) | 1.10 (1.06–1.15) | 1.10 (1.05–1.15) | < 0.001 |
Routine oral care | 68.5 (87/127) | 31.5 (40/127) | – | – | – |
Dental treatment | 70.9 (90/127) | 29.1 (37/127) | 0.92 (0.64–1.34) | 0.92 (0.50–1.67) | 0.779 |
Without adverse events related to oral care | 73.4 (168/229) | 26.6 (61/229) | – | – | – |
With any adverse event related to oral care | 36.0 (9/25) | 64.0 (16/25) | 2.40 (1.67–3.46) | 5.46 (2.11–14.13) | < 0.001 |
Without CHX-induced mucositis | 72.5 (171/236) | 27.5 (65/236) | – | – | – |
With CHX-induced mucositis | 33.3 (6/18) | 66.7 (12/18) | 2.42 (1.64–3.56) | 6.14 (1.98–19.08) | 0.002 |
Without intraoral bleeding | 71 (174/245) | 29 (71/245) | – | – | – |
With intraoral bleeding | 33.3 (3/9) | 66.7 (6/9) | 2.30 (1.40–3.80) | 3.74 (0.75–18.58) | 0.106 |